EPR Properties vs Nuwellis Inc — how do they compare? EPR Properties trades at $60 (market cap $4.58B), while Nuwellis Inc trades at $1.48 (market cap $542.80K). The key difference: EPR Properties is far larger — about 8437.7× Nuwellis Inc's market cap, and EPR Properties pays a 6.22% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| EPR | NUWE | |
|---|---|---|
Market Cap | $4.58B | $542.80K |
Sector | Real Estate | Technology |
52-Week High | $64.32 | $220.50 |
52-Week Low | $48.71 | $1.42 |
Enterprise Value | $8.09B | -$1.27M |
Dividend Yield | 6.22% | — |
Signals from Pluang's Aura AI — not financial advice
EPR Properties trades at $62.20, up 1.4% today, with a neutral technical signal and mixed earnings history including a recent Q2 2026 beat. The company shows strong profitability with a 91.41% gross margin and raised 2026 FFO guidance, supported by a new $1.6 billion credit facility announced on July 20, 2026. Key resistance is at $63, with support at $61.
Outlook is cautiously positive given analyst consensus of $65.30 price target and dividend stability, but risks include declining net income margins and high valuation multiples. Investment appeal hinges on execution of acquisition strategy amid economic sensitivity.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
Latest headlines on both assets
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →